S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
S&P 500   4,005.09 (+0.06%)
DOW   32,522.24 (-0.12%)
QQQ   311.40 (+0.34%)
AAPL   160.14 (+0.54%)
MSFT   276.13 (+0.86%)
META   202.54 (+0.19%)
GOOGL   105.58 (+0.63%)
AMZN   100.14 (-0.47%)
TSLA   197.07 (-0.26%)
NVDA   269.44 (+2.84%)
NIO   9.40 (+1.40%)
BABA   85.17 (+1.76%)
AMD   97.14 (+1.26%)
T   18.60 (+0.32%)
F   11.86 (+1.19%)
MU   58.68 (+0.09%)
CGC   1.97 (-0.25%)
GE   92.32 (+0.15%)
DIS   96.36 (-0.19%)
AMC   4.57 (+3.63%)
PFE   40.48 (-0.44%)
PYPL   75.78 (-1.23%)
NFLX   301.06 (-1.55%)
NYSE:KDMN

Kadmon - KDMN Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$9.50
▼
$9.50
50-Day Range
$9.50
▼
$9.50
52-Week Range
$3.19
▼
$9.50
Volume
1,052 shs
Average Volume
5.11 million shs
Market Capitalization
$1.70 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KDMN stock logo

About Kadmon (NYSE:KDMN) Stock

Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

Receive KDMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kadmon and its competitors with MarketBeat's FREE daily newsletter.

KDMN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive KDMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kadmon and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical Preparation Manufacturing
Sub-Industry
N/A
Sector
Manufacturing
Current Symbol
NYSE:KDMN
CUSIP
N/A
CIK
N/A
Web
N/A
Phone
12123086000
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
178,521,000
Free Float
N/A
Market Cap
$1.70 billion
Optionable
Optionable
Beta
N/A














KDMN Stock - Frequently Asked Questions

What other stocks do shareholders of Kadmon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kadmon investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Organigram (OGI), KushCo (KSHB), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Pennsylvania Real Estate Investment Trust (PEI), Auxly Cannabis Group (CBWTF) and CNBX Pharmaceuticals (CNBX).

When did Kadmon IPO?

(KDMN) raised $101 million in an initial public offering on Wednesday, July 27th 2016. The company issued 5,600,000 shares at a price of $16.00-$20.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

What is Kadmon's stock symbol?

Kadmon trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN."

What is Kadmon's stock price today?

One share of KDMN stock can currently be purchased for approximately $9.50.

How much money does Kadmon make?

Kadmon (NYSE:KDMN) has a market capitalization of $1.70 billion.

How can I contact Kadmon?

Kadmon's mailing address is 450 E 29th St, New York, New York 10016-8367. The company can be reached via phone at 12123086000.

This page (NYSE:KDMN) was last updated on 3/22/2023 by MarketBeat.com Staff